Anadroxyl 50 - Kalpa Pharmaceuticals

Oxymetholone, released by Syntex in the early 1960s, became a staple in anabolic therapy under the brand Anadrol-50. Its ability to increase red blood cell count and stimulate appetite made it valuable for treating anemia and wasting conditions. Unlike most DHT derivatives, it exhibits pronounced estrogenic side effects, which surprised early researchers. Its long-standing use in medical and non-medical contexts highlights both its power and risks—especially hepatotoxicity and cardiovascular strain.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Anadroxyl 50 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.